Abstract Background Transcatheter aortic valve replacement (TAVR) has emerged as a major therapeutic option for treating aortic stenosis. Hyponatremia is
Transcatheter heart valves technologies
Abstract Background Transcatheter aortic valve replacement (TAVR) has emerged as a major therapeutic option for treating aortic stenosis. Hyponatremia is
Transcatheter heart valves technologies
Abstract Background We used transcatheter aortic valve implantation (TAVI) procedure time to investigate the association between surgical team maturity and
Transcatheter heart valves technologies
Abstract Background The aim of this study was to investigate whether the level of decrease in cerebral oxygen saturation during
Transcatheter heart valves technologies
Abstract Background Acute kidney injury (AKI) complicates transcatheter aortic valve replacement (TAVR), leading to higher mortality. The incidence and effects
Transcatheter heart valves technologies
Abstract Background Transcatheter valve-in-valve replacement (TMViVR) is an alternative option for patients with bioprosthetic valve failure (BVF) who are at
Transcatheter heart valves technologies
Abstract Background Patients with active cancer and aortic stenosis may be under-referred for valve interventions due to concerns over a
Transcatheter heart valves technologies
Abstract Background The “weekend effect” on hospital admissions has been extensively studied, showing increased risks for patients admitted on weekends
Transcatheter heart valves technologies
Abstract Clinical outcomes for TAVR in cancer survivors with prior chest radiation therapy (C-XRT) who develop symptomatic aortic-valve stenosis are
Transcatheter heart valves technologies
Abstract Transcatheter aortic valve replacement (TAVR) has become a viable treatment option for patients with severe aortic stenosis among all
Transcatheter heart valves technologies
Abstract Background Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients